EMCV-induced diabetes in mice is attenuated by daily injection of neutralizing antibodies against the cytokines interleukin-1 (IL-1β) or tumor necrosis factor (TNF-α), or administration of aminoguanidine [28], a selective iNOS inhibitor [29,30]. Here, IL1B is linked to diabetes mellitus.